Dimensional Fund Advisors
KPRX icon

Dimensional Fund Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History

Dimensional Fund Advisors’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9K Buy
+12,138
New +$30.5K ﹤0.01% 3207
2023
Q2 		– Sell
-1,362
Closed -$40.9K – 3498
2023
Q1 		$40.9K Buy
+1,362
New +$50.9K ﹤0.01% 3401

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Dimensional Fund Advisors's KPRX Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 12,138 shares worth $31.9K. The stake represents ﹤0.01% of the portfolio and ranks #3207 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in KPRX as recently as Q1 2023.

Dimensional Fund Advisors first reported a position in KPRX in Q1 2023 and has held it in 2 quarters since. The position peaked at $40.9K in Q1 2023. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Dimensional Fund Advisors held 12,138 shares of Kiora Pharmaceuticals worth $31.9K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Dimensional Fund Advisors position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3207 holding.
  • Dimensional Fund Advisors first reported a position in Kiora Pharmaceuticals in Q1 2023 and has held it in 2 quarters since.
  • Dimensional Fund Advisors's Kiora Pharmaceuticals position peaked at $40.9K in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.